US EditionCannabis Rescheduling Given Fresh Hope as DEA Nominee Pledges to 'Look at Science and Listen to Experts' - Business of Cannabis
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Jeff Schultz: From Hedge Fund Lawyer to Cannabis Advocate
In the ever-expanding world of cannabis, few individuals bring a perspective as rare and compelling as Jeff Schultz. A former corporate and securities attorney in the hedge fund industry, Schultz’s transition into cannabis law is a fascinating tale of passion meeting professional expertise. What started as a curiosity back in 2017 has since blossomed into a thriving career, placing him among the nation's top cannabis attorneys.Schultz’s fascinat…
Cannabis Rescheduling Given Fresh Hope as DEA Nominee Pledges to 'Look at Science and Listen to Experts' - Business of Cannabis
Cannabis rescheduling was thrown back into the spotlight last week as the new potential head of the Drug Enforcement Administration (DEA) said it would be a ‘priority’. As previously reported, the ambitious rescheduling process, which would move cannabis from a Schedule I drug to Schedule III, is currently on ice pending the conclusion of an interlocutory appeal into the DEA’s neutrality, and the ball remains in the DEA’s court for now. Just las…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
